A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

NCT05711667 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

105

Enrollment

NETWORK

Sponsor class

Conditions

Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Letermovir

Sponsor

Children's Oncology Group